A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153

Clinical trial NCT02517359 · TERMINATED

Trial details

NCT number: NCT02517359
Sponsor: Respivert Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Healthy Volunteers

Start date: 2015-07-01
Primary completion: 2016-02-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.